Michael Secora
Equibles does not estimate personal net worth.
About Michael Secora
Michael Secora was last confirmed as CFO at Recursion Pharmaceuticals, Inc. (RXRX) in a filing dated April 23, 2024. The proxy statement of Recursion Pharmaceuticals, Inc. reports total compensation of $5,043,506 for Michael Secora in fiscal 2024, including a base salary of $475,000. Disclosed compensation is on record for 5 fiscal years.
Affiliation history
-
Start not stated–2024-04-23
Last confirmed by a filing; no departure on record
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Recursion Pharmaceuticals, Inc. (RXRX) | Former Chief Financial Officer | $475,000 | $5,043,506 |
| 2023 | Recursion Pharmaceuticals, Inc. (RXRX) | Former Chief Financial Officer | $435,583 | $4,514,381 |
| 2022 | Recursion Pharmaceuticals, Inc. (RXRX) | Former Chief Financial Officer | $348,250 | $2,090,422 |
| 2021 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Financial Officer | $307,708 | $510,342 |
| 2020 | Recursion Pharmaceuticals, Inc. (RXRX) | Chief Financial Officer | $170,833 | $3,718,488 |
Recent activity
No call appearances or filed executive changes recorded yet.